Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer

NCT01042041 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Liver Cancer
Localized Unresectable Liver Cancer

Interventions

DRUG: sorafenib tosylate
DRUG: doxorubicin hydrochloride
DRUG: cisplatin
DRUG: mitomycin C
PROCEDURE: transarterial chemoembolization
PROCEDURE: hepatic artery embolization

Sponsor

Abramson Cancer Center at Penn Medicine